Dear Colleague,
We are pleased to present the 7th Drug Design &
Medicinal Chemistry Conference on May 8-10, 2013 in Boston,
MA. The challenges facing our industry are being met by innovation in all areas
of research, from methods for identification of new targets to efficient
informatics. We invite you to join us at a multi-disciplinary meeting where lead
investigators in the areas of epigenetics, protein::protein targets, fragment
screening technologies and more will share perspectives in these exciting
fields.
A few topics our delegates can look forward to
learning about:
-
Case studies in successful modulators of neural, oncology and immunological
targets
-
The use of small molecules to engineer human immune responses
-
How in silico tools are being used in the design of new
therapeutic agents
-
Perspectives on Chemical Biology and whole organism screening
-
Experimental and computational advances in fragment-screening
An overview of the conference agenda:
-
Emerging Targets
in Drug Discovery
-
New
Computational Methods in Drug Design
-
Novel Methods in
Drug Design
-
Advances in
Hit-Finding Strategies
To view the complete agenda, click
here.
To view the speaker list, click
here.
This conference is co-located with three others in our
3rd
Epigenetics in Drug Discovery
6th Imaging in
Drug Discovery and Development
Inaugural Orphan Drugs Research & Commercialization
Sign up for a summit pass to
have access to all four conferences.
We hope you’ll join us in Boston for this
exciting meeting!
Best regards,
The 2013 Advisory Committee
|
| GOLD
SPONSORS |
|
 |
|
| PLATINUM
SPONSOR |
|
 |
|
|
MEDIA
PARTNERS |
|
 |
|
 |
|
|
SUPPORTING SPONSOR |
|
 |
|
|
|
|
